# Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer

Source: https://onco.cc/trials/nct04722978/  
OnCo record `nct04722978` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of gemcitabine and carboplatin in triple-negative breast cancer, run by Sun Yat-Sen University Cancer Center, now recruiting.

## Summary

Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer is a phase 3, randomised interventional study registered as NCT04722978 by Sun Yat-Sen University Cancer Center, with a registry enrolment figure of 228 participants, started 2021-04-20 and due to reach its primary completion in 2026-06. Interventions recorded: Gemcitabine and carboplatin plus antibiotic (moxifloxacin); Gemcitabine combined with carboplatin plus placebo. Conditions listed: Triple Negative Breast Cancer. Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; tnbc-deep-dive
- Registry id: NCT04722978
- Phase: 3
- Setting: Standard Chemotherapy Plus Moxifloxacin as First-line Treatment for Metastatic Triple-negative Breast Cancer : a Multicenter, Double-blind, Placebo-controlled, Phase 3 Trial
- Sponsor: Sun Yat-Sen University Cancer Center
- Enrolled: 228

## Sources

- ClinicalTrials.gov NCT04722978: https://clinicaltrials.gov/study/NCT04722978

## Connected records

- cancers: [Metastatic triple-negative breast cancer](https://onco.cc/cancers/tnbc-metastatic/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Gemcitabine](https://onco.cc/drugs/gemcitabine/)
- terms: [Triple-negative breast cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/tnbc-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct04722978.json